Cytokine release syndrome complicated with rhabdomyolysis after chimeric antigen receptor T-cell therapy: A case report

BACKGROUND: Chimeric antigen receptor T-Cell (CAR-T) therapy is an effective new treatment for hematologic malignancies. Cytokine release syndrome (CRS) and neurologic toxicity are main toxicities. CRS-induced rhabdomyolysis (RM) followed by CAR-T therapy treatment has not been previously reported....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lan, Chen, Wei, Wang, Xiao-Min, Zhang, Shu-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477680/
https://www.ncbi.nlm.nih.gov/pubmed/36159401
http://dx.doi.org/10.12998/wjcc.v10.i26.9398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477680/
https://www.ncbi.nlm.nih.gov/pubmed/36159401
http://dx.doi.org/10.12998/wjcc.v10.i26.9398

Ejemplares similares